Florian Raes

Grenoble, 38000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Comparative theranostic efficacy of 177Lu- and 161Tb-labeled A1K2 SdAb in mesothelin-positive tumors.

Comparative theranostic efficacy of 177Lu- and 161Tb-labeled A1K2 SdAb in mesothelin-positive tumors.

Journal: European journal of nuclear medicine and molecular imaging

Published: September 17, 2025

PD-L1 Immuno-PET Reveals Systemic Effects of Localized Oncolytic Virotherapy in a Mouse Model of Head and Neck Cancer.

PD-L1 Immuno-PET Reveals Systemic Effects of Localized Oncolytic Virotherapy in a Mouse Model of Head and Neck Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: August 03, 2025

Side by side comparison of NOTA and DOTA for conjugation efficiency, gallium-68 labeling, and in vivo biodistribution of anti-mesothelin sdAb A1-His.

Side by side comparison of NOTA and DOTA for conjugation efficiency, gallium-68 labeling, and in vivo biodistribution of anti-mesothelin sdAb A1-His.

Journal: EJNMMI radiopharmacy and chemistry

Published: May 12, 2025

Enhancing theranostic potential of anti-mesothelin sdAb through site-specific labeling at a unique conserved lysine by molecular engineering.

Enhancing theranostic potential of anti-mesothelin sdAb through site-specific labeling at a unique conserved lysine by molecular engineering.

Journal: EJNMMI radiopharmacy and chemistry

Published: January 27, 2025

Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance.

Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance.

Journal: Cancer research communications

Published: July 12, 2023

TrisOxine abiotic siderophores for technetium complexation: radiolabeling and biodistribution studies.

TrisOxine abiotic siderophores for technetium complexation: radiolabeling and biodistribution studies.

Journal: EJNMMI radiopharmacy and chemistry

Published: July 07, 2023

Correction: Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy.

Correction: Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy.

Journal: BMC medicine

Published: May 03, 2022

Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy.

Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy.

Journal: BMC medicine

Published: September 29, 2021

In Vivo Biodistribution and Efficacy Evaluation of NeoB, a Radiotracer Targeted to GRPR, in Mice Bearing Gastrointestinal Stromal Tumor.

In Vivo Biodistribution and Efficacy Evaluation of NeoB, a Radiotracer Targeted to GRPR, in Mice Bearing Gastrointestinal Stromal Tumor.

Journal: Cancers

Published: February 03, 2021

Immunomodulatory activity of IR700-labelled affibody targeting HER2.

Immunomodulatory activity of IR700-labelled affibody targeting HER2.

Journal: Cell death & disease

Published: November 12, 2019

Development of an embedded multimodality imaging platform for onco-pharmacology using a smart anticancer prodrug as an example.

Development of an embedded multimodality imaging platform for onco-pharmacology using a smart anticancer prodrug as an example.

Journal: Scientific reports

Published: August 12, 2019

Targeting the tumour microenvironment with an enzyme-responsive drug delivery system for the efficient therapy of breast and pancreatic cancers.

Targeting the tumour microenvironment with an enzyme-responsive drug delivery system for the efficient therapy of breast and pancreatic cancers.

Journal: Chemical science

Published: January 31, 2017

Showing 1-12 of 15

Last Updated: 09/26/2026